BENEDETTI, Rosaria
 Distribuzione geografica
Continente #
EU - Europa 4.976
NA - Nord America 2.789
AS - Asia 1.837
SA - Sud America 404
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 10.030
Nazione #
RU - Federazione Russa 3.526
US - Stati Uniti d'America 2.742
SG - Singapore 631
IT - Italia 456
IE - Irlanda 425
CN - Cina 415
BR - Brasile 335
HK - Hong Kong 282
VN - Vietnam 169
KR - Corea 128
DE - Germania 124
GB - Regno Unito 108
UA - Ucraina 92
IN - India 70
FI - Finlandia 47
AR - Argentina 36
SE - Svezia 30
FR - Francia 29
GR - Grecia 26
JP - Giappone 26
NL - Olanda 24
TR - Turchia 24
CA - Canada 20
MX - Messico 19
AT - Austria 17
PK - Pakistan 17
EC - Ecuador 15
DK - Danimarca 12
HU - Ungheria 12
ES - Italia 11
IQ - Iraq 11
BD - Bangladesh 10
UZ - Uzbekistan 8
ID - Indonesia 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
PL - Polonia 6
IL - Israele 5
MA - Marocco 5
VE - Venezuela 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CO - Colombia 4
KE - Kenya 4
LT - Lituania 4
PT - Portogallo 4
TW - Taiwan 4
BO - Bolivia 3
LK - Sri Lanka 3
NP - Nepal 3
ZA - Sudafrica 3
AL - Albania 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IM - Isola di Man 2
KZ - Kazakistan 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AU - Australia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 10.030
Città #
Moscow 1.249
Chicago 535
Wilmington 433
Dublin 423
Falls Church 334
Singapore 319
Hong Kong 282
Santa Clara 259
Chandler 193
Jacksonville 135
Seoul 126
Hefei 93
Naples 90
Beijing 80
Ashburn 72
Ho Chi Minh City 57
Bengaluru 54
New York 49
Caserta 47
Princeton 44
Munich 37
Roxbury 37
Boardman 35
Dallas 34
The Dalles 34
Hanoi 30
Medford 29
São Paulo 27
Dong Ket 26
Aversa 24
Los Angeles 22
Ann Arbor 16
Milan 16
Cambridge 15
Napoli 14
Stuttgart 14
Bremen 13
Nuremberg 13
Houston 12
Rio de Janeiro 12
Rome 12
Vienna 12
Buenos Aires 11
Belo Horizonte 10
Copenhagen 10
Des Moines 10
San Mateo 10
Brooklyn 8
Curitiba 8
Helsinki 8
London 8
Mountain View 8
San Giuseppe Vesuviano 8
Tashkent 8
Turku 8
Afragola 7
Amsterdam 7
Cicciano 7
Lappeenranta 7
Mexico City 7
Montreal 7
Quito 7
Woodbridge 7
Boston 6
Brussels 6
Groningen 6
Guangzhou 6
Haiphong 6
Hải Dương 6
Jakarta 6
Porto Alegre 6
Salvador 6
Seattle 6
Shanghai 6
Tianjin 6
Viterbo 6
Warsaw 6
Boydton 5
Brasília 5
Chennai 5
Columbus 5
Florence 5
Nanjing 5
Recife 5
San Francisco 5
Stockholm 5
Vico Equense 5
Airola 4
Bacoli 4
Barcelona 4
Cascina 4
Casoria 4
Charlotte 4
Dhaka 4
Ercolano 4
Falkenstein 4
Frankfurt am Main 4
Istanbul 4
Lisbon 4
Ludwigsburg 4
Totale 5.715
Nome #
Epigenetic mechanisms underlying prostate cancer radioresistance 1.415
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 187
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 163
HIF3A inhibition triggers browning of white adipocytes via metabolic rewiring. 160
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma 159
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 157
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 156
Deregulation of new cell death mechanisms in Leukemia 155
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 149
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients:a meta-analysis of randomized clinical trials 148
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 145
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 141
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 138
Epigenetic-based therapy: From single- to multi-target approaches 138
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 136
Breast Cancer Vaccines: New Insights 135
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics 134
HAT1: Landscape of Biological Function and Role in Cancer 131
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells 127
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine Specific Demethylases Display High Anticancer Activities. 126
Involvement of regulated cell deaths in aging and age-related pathologies 125
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 125
HDAC6 inhibition extinguishes autophagy in cancer: Recent insights 125
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 123
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 123
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification 121
Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives 121
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 121
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 119
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer 119
Design and Synthesis of New Oligopeptidic Parvulin Inhibitors 118
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer 114
EPIGENETIC-BASED DRUGS IN STEM CELL DIFFERENTIATION 114
Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research 114
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 114
EPIGENETIC MODULATION OF LAT1 EXPRESSION TO ENHANCE OSTEOSARCOMA SENSITIVITY TO BORON NEUTRON CAPTURE THERAPY (BNCT) 113
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 113
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity 113
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy 113
Modulation of Autophagy and Apoptosis in Leukemia 111
From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment 110
FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma 110
The role of SAHA in boron uptake: harnessing epigenetic regulation of LAT1 for optimized BNCT 110
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells. 110
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 109
I BET on anti-FGFR to fight cancer resistance 108
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues 107
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 106
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90 106
Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome 105
DNA Mutations via Chern-Simons Currents 105
Whole-Genome Bisulfite Sequencing of Two Distinct Interconvertible DNA Methylomes of Mouse Embryonic Stem Cells. 102
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 101
The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: Evidence in human cardiomyocyte cell line 100
Role of Ferroptosis in AML Pathophysiology and Therapeutic Strategies 100
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia- exposed human cardiomyocytes through comprehensive multi-level analysis 100
Unravelling the impact of the chromobox proteins in human cancers 99
Harnessing normalcy: The potential of healthy tissuefor patient outcomes 97
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game? 96
Targeting HDACs in diseases: where are we? 96
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 95
Nonlinear protein – nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells 94
New Anacardic Acid-Inspired Benzamides: Histone Lysine Acetyltransferase Activators 91
Current Preclinical Applications of Pharmaco-Epigenetics in Cardiovascular Diseases 90
Trials with 'epigenetic' drugs: An update. 89
Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes 89
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis 89
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 88
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors 85
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 83
Psidium guajava L. anti-neoplastic effects: induction of apoptosis and cell differentiation. 83
Structure-Activity Relationships on Cynnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase 82
The innovative potential of selenium-containing agents for fighting cancer and viral infections 82
Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs) 80
In-Depth Exploration of Radiation-Induced Cell Death Mechanisms in Tumor 80
“Aging and epigenetic implications in radiotherapy: The promise of BNCT” 76
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 73
Phase separation rewires chromatin in breast cancer 66
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 44
Totale 10.195
Categoria #
all - tutte 29.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 2 35 23 10 22 31 37
2021/20221.169 80 137 253 95 163 42 40 31 27 81 62 158
2022/20231.271 143 110 339 57 68 49 5 41 415 10 13 21
2023/2024442 30 13 16 21 88 65 16 34 11 31 36 81
2024/20251.465 15 39 46 70 206 158 253 133 165 118 128 134
2025/20265.224 306 355 358 323 515 3.367 0 0 0 0 0 0
Totale 10.195